- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Argo Sante
Total 3202 results
-
Argo SanteGenSight BiologicsCompleted
-
Argo SanteFilière de santé maladies rares MCGRE; Fédération des malades drépanocytaires... and other collaboratorsCompleted
-
CARGO TherapeuticsRecruitingCancer | Relapsed/Refractory Large B-cell Lymphoma (LBCL)United States
-
Laboratoires URGOCompleted
-
Laboratoires URGOUnknownDiabetic Foot UlcerCzechia, France, Italy, Poland, Spain, United Kingdom
-
Laboratoires URGOUnknown
-
Argos TherapeuticsTerminated
-
Laboratoires URGOUnknownDiabetic Foot Ulcer(s)France
-
Argos TherapeuticsCompleted
-
Argos TherapeuticsCompleted
-
Laboratoires URGORecruitingDiabetic Foot Ulcer | Venous Leg Ulcer | Real Life Study | TLC-NOSF Dressings | QoL QuestionnaireFrance
-
Laboratoires URGORecruitingWound Infection | Diabetic Foot Ulcer | Venous Leg Ulcer | Pressure Ulcer | Acute WoundsFrance
-
Laboratoires URGOCompleted
-
Argos TherapeuticsCompletedKidney Cancer | Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States
-
Laboratoires URGOUnknown
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
Laboratoires URGOCompleted
-
Argos TherapeuticsCompletedRenal Cell CarcinomaCanada, United States
-
Argos TherapeuticsCompletedHIV InfectionsCanada, United States
-
Argos TherapeuticsCompletedInflammation | Systemic Lupus Erythematosus (SLE)United States
-
Laboratoires URGOUnknown
-
Laboratoires URGOUnknown
-
Laboratoires URGOUnknownVenous Leg Ulcer
-
Argos TherapeuticsTerminatedRenal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaIsrael, Spain, United States, Czechia, Canada, Italy, Hungary, United Kingdom
-
Argos TherapeuticsCompletedHIV InfectionUnited States, Canada
-
Arno TherapeuticsUnknownProgesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone TherapyFrance
-
Arno TherapeuticsUnknownGlioblastoma Multiforme | Gliosarcoma | GBMUnited States, Canada
-
Arno TherapeuticsUnknown
-
Arno TherapeuticsCompletedLymphoma | Solid TumorsUnited States, United Kingdom
-
Laboratoires URGOUnknownAttention Deficit Hyperactivity DisorderFrance
-
Arga Medtech SARecruitingAtrial FibrillationGeorgia
-
Arog Pharmaceuticals, Inc.CompletedPhase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsRelapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior TherapiesUnited States
-
Arog Pharmaceuticals, Inc.CompletedRecurrent/Refractory GlioblastomaUnited States
-
Arog Pharmaceuticals, Inc.CompletedEsophagogastric AdenocarcinomaUnited States
-
Arog Pharmaceuticals, Inc.AvailableFLT3-ITD Mutation | FLT3/TKD Mutation | PDGFR-Alpha D842V | PDGFRA Gene AmplificationItaly
-
Arog Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States, Australia
-
Arog Pharmaceuticals, Inc.RecruitingNewly Diagnosed FLT3 Mutated AMLUnited States
-
Arog Pharmaceuticals, Inc.RecruitingRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States, Germany, Spain, Italy, France, Canada
-
Arog Pharmaceuticals, Inc.WithdrawnRelapsed/Refractory FLT3-mutated AML
-
Arog Pharmaceuticals, Inc.Terminated
-
Arog Pharmaceuticals, Inc.CompletedD842-related Mutant GISTUnited States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Arog Pharmaceuticals, Inc.CompletedNewly Diagnosed AML With FLT3 Activating MutationsUnited States
-
Arog Pharmaceuticals, Inc.CompletedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Arog Pharmaceuticals, Inc.WithdrawnCarcinoma, Non-Small-Cell Lung
-
Aro BiotherapeuticsRecruiting
-
ARO MedicalUnknownLumbar Disc Prolapse With RadiculopathyDenmark